Home > Healthcare > Medical Devices > Therapeutic Devices > Home Infusion Therapy Market

Home Infusion Therapy Market Share

Report ID: GMI435
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Home Infusion Therapy Market Share

The market is characterized by a mix of established healthcare providers, pharmaceutical companies, and specialized home healthcare service providers. These companies offer a wide range of infusion therapies and services, leveraging economies of scale and comprehensive patient care solutions. Additionally, pharmaceutical firms like Fresenius Kabi and B. Braun Melsungen AG play significant roles by supplying infusion products and collaborating with healthcare providers to expand their market footprint. The market is also witnessing increased competition from regional players and new entrants focusing on technological innovations, personalized patient care, and strategic partnerships to differentiate their offerings and capture market share in this rapidly growing segment of healthcare delivery.

Home Infusion Therapy Market Companies

Prominent players operating in the home infusion therapy industry include:

AMERITA INC.
Amsino International, Inc.
B. Braun Melsungen AG
Baxter International Inc.
Becton Dickinson and Company
Contec Medical Systems Co. Ltd
Erenler Medikal
Fresenius Kabi
Halyard Health, Inc. (Avanos Medical)
ICU Medical Inc.
JMS Co. Ltd.
Lepu Medical Technology
Moog Inc.
Option Care Health, Inc.
Terumo Corporation

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Home infusion therapy industry size was worth USD 31.9 billion in 2023 and is projected to expand at 11% CAGR from 2024 to 2032, due to the rising prevalence of chronic diseases, favorable reimbursement policies, and increasing patient preference for home-based care.

The infusion pumps product segment in the home infusion therapy industry recorded USD 16 billion in 2023 and is estimated to witness substantial growth between 2024 and 2032, due to the development of new drug formulations that are suitable for home infusion therapy.

The anti-infective application segment in the home infusion therapy industry recorded 27% share in 2023 and is projected to grow at significant rate from 2024 to 2032, on account of the rising incidence of bacterial, viral, and fungal infections.

North America home infusion therapy market recorded USD 13.8 billion in revenue in 2023 and is projected to expand at 10.3% CAGR between 2024 and 2032, due to the increasing healthcare expenditure in the region.